AMAG Pharmaceuticals, Inc. (AMAG) Posts Q4 Loss of 17c/Share; Updates Outlook
Tweet Send to a Friend
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q4 EPS of ($0.17), $0.07 worse than the analyst estimate of ($0.10). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
